COVID-19 and rheumatology: first steps towards a different future?

Affiliations

Editorial

Iain B McInnes. Ann Rheum Dis. 2020 May.

. 2020 May;79(5):551-552.

doi: 10.1136/annrheumdis-2020-217494.

¹ Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8QQ, UK iain.mcinnes@glasgow.ac.uk.

No abstract available

Keywords: arthritis, rheumatoid; rehabilitation; rheumatoid factor.

Conflict of interest statement

Competing interests: None declared.

Hydroxychloroquine shortages during the COVID-19 pandemic.
Mendel A, Bernatsky S, Thorne JC, Lacaille D, Johnson SR, Vinet É. Mendel A, et al. Ann Rheum Dis. 2021 Mar;80(3):e31. doi: 10.1136/annrheumdis-2020-217835. Epub 2020 May 20. Ann Rheum Dis. 2021. PMID: 32434820 No abstract available.
Response to: 'Hydroxychloroquine shortages during the COVID-19 pandemic' by Mendel et al.
McInnes I. McInnes I. Ann Rheum Dis. 2021 Mar;80(3):e32. doi: 10.1136/annrheumdis-2020-217954. Epub 2020 May 20. Ann Rheum Dis. 2021. PMID: 32434826 No abstract available.

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Zhou F, et al. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Lancet. 2020. PMID: 32171076 Free PMC article.
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.
Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C. Monti S, et al. Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2. Ann Rheum Dis. 2020. PMID: 32241793 Free PMC article. No abstract available.